Evox Therapeutics

This page shows the latest Evox Therapeutics news and features for those working in and with pharma, biotech and healthcare.

Duchenne UK backs Evox dystrophin delivery project

Funding will drive preclinical studies on dystrophin-bearing exosomes. Oxford University spin-out Evox Therapeutics has won a £656, 000 ($858, 000) grant from a UK medical charity to test its ... Evox spun out of Oxford University in 2016 with £10m in

Latest news

Redmile and Google help Evox raise £35.5m for exosome pipeline

It is reported that GV contributed £10m of the total. Oxford University spin-out Evox Therapeutics has raised £35.5m (around $45m) in a second-round financing that will be used ... The Series B funding will also be used to develop the exosome delivery

More from news
Approximately 2 fully matching, plus 0 partially matching documents found.

Latest appointments

Robert Freisen joins Ablynx

He succeeds Dr Antonin de Fougerolles, who left the company last year to become Evox Therapeutics’ chief executive officer. ... He has previously held roles for ProQR Therapeutics, Janssen BioTherapeutics, and MorphoSys.
Tony de Fougerolles joins Evox Therapeutics as CEO

Oxford, UK-based Evox Therapeutics has appointed its new chief executive officer in the form of Tony de Fougerolles. ... Dr Lundin said: “After a thorough selection process, I am incredibly pleased that Tony is joining the team as we continue to